American Public Education Earnings Call Transcripts
Fiscal Year 2026
-
The business expects to grow revenue from $650M in 2025 to up to $1B by 2029, driven by strong positions in military and nursing education, margin expansion, and new growth initiatives. Cash generation will support investments in AI, campus expansion, and potential acquisitions.
-
Strong enrollment and revenue growth in key segments drove robust 2025 financial results, with $13.7 million in annualized savings initiatives set for 2026. All board proposals, including director elections, executive compensation, and auditor ratification, were approved by majority vote.
-
Q1 2026 saw revenue up 6.2% YoY (8.7% ex-divestiture), Adjusted EBITDA up 37.5%, and EPS up 129%. Guidance for 2026 was raised across revenue, EBITDA, and EPS, with strong Health+ growth and Military+ facing temporary deployment headwinds.
Fiscal Year 2025
-
Delivered 4% revenue growth and 19% higher adjusted EBITDA in 2025, overcoming a government shutdown and divestiture. 2026 guidance projects continued revenue and margin expansion, with new campuses and a $50 million share repurchase program supporting growth.
-
Management outlined a plan to reach $890–$925 million in organic revenue and $182–$200 million in adjusted EBITDA by 2029, driven by new programs, global expansion, and digital transformation. RU Health Plus and APUS will focus on maximizing capacity, launching new campuses, and leveraging technology for growth and efficiency.
-
Q3 2025 results exceeded guidance, with revenue up 7% and adjusted EBITDA up 60% year-over-year. Strong enrollment growth at Rasmussen and Hondros offset APUS headwinds from a government shutdown, while cost reductions and asset sales improved cash flow and capital structure.
-
Q2 2025 results exceeded guidance with strong revenue and adjusted EBITDA growth, driven by double-digit enrollment increases at Rasmussen and Hondros. Balance sheet was strengthened through asset sales and preferred equity redemption, while full-year guidance was maintained or raised.
-
Strong momentum in military and nursing education, with lifted growth restrictions enabling campus expansion and improved financials. Consolidation of institutions aims to drive synergies by 2026, while regulatory relationships and market demand remain favorable.
-
Q1 2025 results exceeded guidance with revenue up 6.6% and adjusted EBITDA up 25% year-over-year. Full-year adjusted EBITDA and net income guidance were raised, while Graduate School USA remains a drag due to federal budget uncertainty. Institutional consolidation and preferred stock redemption are expected to drive further profitability.
Fiscal Year 2024
-
Q4 and full year 2024 results exceeded guidance, with strong revenue and EBITDA growth across all segments. Rasmussen and Hondros posted robust enrollment gains, and a major institutional consolidation is planned for 2025 to drive further synergies and margin expansion.
-
Q3 2024 saw 1.5% revenue growth to $153M, with adjusted EBITDA above guidance and net income at the high end. Rasmussen and Hondros posted strong enrollment gains, and full-year revenue and EBITDA guidance were raised. Nursing and military/veteran education demand remains strong.
-
Q2 2024 saw 3.9% revenue growth and a 24% increase in adjusted EBITDA, with Rasmussen achieving its first positive year-over-year revenue and enrollment quarter since acquisition. Full-year guidance is reiterated, and Rasmussen is expected to reach positive EBITDA in Q4 2024.
-
The conference highlighted strong market positioning in military and nursing education, robust financial performance, and operational improvements driving cost savings and margin expansion. Growth restrictions on Rasmussen will lift by end-2024, enabling new campus openings and further organic growth.